Blueprint Medicines
develop targeted disease treatments
- B2B
About Blueprint Medicines
Develop targeted medicines addressing allergy, inflammation, oncology, and hematology by focusing on root causes and advancing clinical programs.
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- cambridge, massachusetts, United States
- Founded
- 2011
- Revenue
- $509MFY2024, publicly reported
- Website
- blueprintmedicines.com
Blueprint Medicines at a glance
Blueprint Medicines is a B2B company in the Biotechnology Research industry, headquartered in cambridge, massachusetts, United States.
Blueprint Medicines was founded in 2011.
Blueprint Medicines has 251–1,000 employees.
Blueprint Medicines's revenue is $509M (FY2024, publicly reported).
Frequently asked questions about Blueprint Medicines
What is Blueprint Medicines's revenue?
Blueprint Medicines's revenue is $509M (FY2024, publicly reported).
How many employees does Blueprint Medicines have?
Blueprint Medicines has 251–1,000 employees.
Where is Blueprint Medicines headquartered?
Blueprint Medicines is headquartered in cambridge, massachusetts, United States.
Selling to companies like Blueprint Medicines?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies